Aspo Plc
Aspo Plc: Share repurchase 12.11.2025
Aspo Plc: Share repurchase 12.11.2025
| Aspo Plc | ANNOUNCEMENT | 12.11.2025 |
| Aspo Plc: Share repurchase 12.11.2025 | ||
| In the Helsinki Stock Exchange | ||
| Trade date | 12.11.2025 | |
| Bourse trade | Buy | |
| Share | ASPO | |
| Amount | 3 000 | Shares |
| Average price/ share | 6,8620 | EUR |
| Total cost | 20 586,00 | EUR |
| Aspo Plc now holds a total of 19 068 shares | ||
| including the shares repurchased on 12.11.2025 | ||
| The share buybacks are executed in compliance with Regulation | ||
| No. 596/2014 of the European Parliament and Council (MAR) Article 5 | ||
| and the Commission Delegated Regulation (EU) 2016/1052. | ||
| On behalf of Aspo Plc | ||
| Nordea Bank Oyj | ||
| Sami Huttunen | Ilari Isomäki | |
| For more information, please contact: | ||
| Erkka Repo, CFO, Aspo Plc, tel. +358 40 5827 971, erkka.repo@aspo.com | ||
| www.aspo.com | ||
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SBM Offshore Amsterdam B.V.12.11.2025 18:13:35 CET | Press release
SBM Offshore announces proposed CEO and Supervisory Board reappointments
BetaGlue Therapeutics SpA12.11.2025 18:00:00 CET | Press release
MHRA Approves BetaGlue Therapeutics’ Clinical Trial Application for YntraDose™ in unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)
Verkkokauppa.com Oyj12.11.2025 18:00:00 CET | Press release
Verkkokauppa.com Oyj: Acquisition of own shares on 12 November 2025
LECTRA12.11.2025 17:58:51 CET | Press release
Lectra: Monthly declaration of the total number of shares and voting rights composing the company's capital (at October 31st, 2025)
Statkraft AS12.11.2025 17:51:10 CET | Press release
S&P downgrades Statkraft’s credit rating from A to A-, in line with the company’s long-standing rating target
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom